Jennifer Doudna’s Innovative Genomics Institute (IGI) has launched an ambitious effort to establish a COVID-19 diagnostic testing laboratory on UC Berkeley campus. The UC Berkeley Tang Center and medical centers around the East Bay will collect patient samples, and will test these samples for SARS-CoV-2, the virus that causes COVID-19. The IGI is a Bay Area research partnership founded by Jennifer Doudna, co-developer of CRISPR. “We are interested in serving the public good,” said Doudna. “The expertise in our institute and in our community can address this public health emergency through the kind of coordination we are uniquely capable of.”
Source: The Innovative Genomics Institute (IGI)
Picture credit: Innovative Genomics Institute (IGI)
